USD 6.57 billion
Protein Therapeutics Market Size, Share, Growth Analysis, By Product Type(Monoclonal Antibodies, Insulin, Vaccines, Growth Hormones), By Application(Oncology, Hematology, Immunology, Metabolic Disorders), By Therapeutic Area(Cancer, Diabetes, Infectious Diseases, Autoimmune Disorders), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2238 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
99
|Figures:
76
Protein Therapeutics Market Insights
Global Protein Therapeutics Market size was valued at USD 6.57 billion in 2022 and is poised to grow from USD 6.96 billion in 2023 to USD 11.10 billion by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).
Growing demand for efficient, multi-ailment treatments has led to an increase in protein therapeutics. As chronic illnesses like diabetes, autoimmune disorders, and cancer increase, there is a growing need for protein-based therapies. The prevalence of these diseases has increased due to the rising global ageing population. Small-molecule drugs are not as well-liked as biologics. Due to biologics' superior efficacy, less side effects, and great specificity, they are growing in popularity. The market has expanded due to the most common protein therapy, monoclonal antibodies. Protein engineering and biotechnology developments have propelled market expansion. Researchers and pharmaceutical companies have undertaken the use of advanced technologies to develop more potent protein medicines. Thus, augmenting therapeutic options to invent next-generation biologics like fusion proteins and bispecific antibodies.
Treatments for cancer involve proteins, particularly monoclonal antibodies. The number of tailored cancer treatments has increased in recent years. The importance of these medicines in the treatment of cancers is growing, as these drugs can kill cancer cells by targeting them and not other healthy tissues of the body. Protein replacement therapies (PRTs) have attracted a lot of attention and development. Organizations and governments all over the world are encouraging research and development of therapies for rare diseases through financial incentives and special designations. In order to address the medical needs of underprivileged patient populations, this tendency has prompted research and development initiatives. Protein treatment is evolving as a result of biosimilar applications. Biosimilars are being released by several original biologics that are losing their patents.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Monoclonal Antibodies
Fastest Growth
Insulin
Growth Rate
6% CAGR
Global Protein Therapeutics Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Protein Therapeutics Market Segmental Analysis
The global Protein Therapeutics market is segmented into four major segments i.e. by Product Type, Application, Therapeutic Area, and region. Based on Type, it is divided into Monoclonal Antibodies, Insulin, Vaccines, Growth Hormones, Blood Clotting Factors, Enzyme Replacement Therapies. Based on Application, it is bifurcated as Oncology, Hematology, Immunology, Metabolic Disorders, Cardiovascular Disorders, Others. Based on Therapeutic Area it is segregated into Cancer, Diabetes, Infectious Diseases, Autoimmune Disorders, Genetic Disorders, and Others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Analysis by Type
As per categorization by products type, the market is classified as monoclonal antibodies, insulin, fusion protein, erythropoietin, and interferon. Among these, monoclonal antibodies earned the largest share and continue to hold the dominant global protein therapeutics market share. Monoclonal antibodies (mAbs) are driving innovation in the global protein therapeutics market due to their precision in targeting specific proteins involved in diseases. They are also expected to target cancer immunotherapy, autoimmune diseases, and infectious diseases, for creating focused very effective treatments. Monoclonal antibodies dominate the entire market due to their high specificity, low unwanted side effects, and capability to treat very complex diseases. Further, the advancements in biotechnology and rising trend toward personalized medicine are causing the expansion of protein-based therapies.
Insulin is poised to be the fastest-growing segment in the global protein therapeutics market due to the increasing prevalence of diabetes worldwide. As the demand for diabetes management solutions rises, insulin therapies are becoming more advanced, with innovations like rapid-acting insulins and long-acting formulations improving patient outcomes. The expanding aging population, rising obesity rates, and growing awareness of diabetes drive market growth. Furthermore, advancements in insulin production, like biosimilars and new delivery systems, will make insulin therapy more available, affordable, and effective thereby further accelerating its growth within the protein therapeutic sector.
Analysis by Application
Metabolic disorders are experiencing significant innovation in the global protein therapeutics market, driven by advances in targeted therapies and biologics. Progressive protein therapies are mostly directed towards conditions such as obesity, type-2 diabetes, and infrequent genetic disorders like phenylketonuria. These have enhanced treatment benefits with respect to enzyme replacement therapies, gene therapy, and peptide-based drugs, as these therapies target the causative factors associated with the diseases. The growing tide of metabolic diseases and increasing healthcare awareness have caused an escalation in the demand for customized treatments, making metabolic disorders their dominant space in the protein therapeutics market. Thus, they are well assured of continued expansion and relevance in the future.
Cancer is set to become the fastest-growing segment in the global protein therapeutics market due to the increasing global incidence of various cancer types and the growing demand for more targeted, effective treatments. Revolutionizing cancer care with targeted therapies with fewer side effects are innovations in monoclonal antibodies, immune checkpoint inhibitors, and CAR-T therapies. The further evolution of cancer therapeutics will be ensued by an increase in personalized medicine, paved alongside the innovation path that biotechnology and genomics are trailing along. Most growth drivers anticipated in the years to come in the protein therapeutics market will be mostly from cancer treatment options that will be developed around new research hypotheses and an increased thrust into immuno-oncology.
Global Protein Therapeutics Market By Type (%)
To get detailed analysis on other segments, Request For Free Sample Report
Protein Therapeutics Market Regional Insights
North America dominates the global protein therapeutics market due to its advanced healthcare infrastructure, robust biotechnology sector, and significant investment in research and development. Innovation-based protein therapy development and approval, commercialization mostly occurs in the U.S. This is complemented by the strong regulatory frameworks and an outsize presence of most pharmaceutical companies in the country. Chronic diseases like cancer and metabolic disorders are on the rise. Healthcare spending continues growing, and there is an increase in personalized medicine, which propels demand for protein therapeutics. Major thrusts for the region, particularly North America, are new medical research and robust healthcare reimbursement policies that keep defining leadership in the market.
Asia-Pacific is the fastest-growing region in the global protein therapeutics market due to its rapidly expanding healthcare infrastructure, large patient population, and rising demand for advanced medical treatments. China and India are among those countries well-endowed with enormous economic growth and thus high healthcare investments and facilities for improved access to novel therapies. So, the future of this market expansion is also strengthened by the region's emphasis on biotech and pharmaceutical research and increasing government support for innovations in health care. Demand for protein therapeutics in the Asia-Pacific region is also supported by an increase in chronic diseases and the gradually rising middle class that is becoming more and more aware of health issues.
Global Protein Therapeutics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Protein Therapeutics Market Dynamics
Protein Therapeutics Market Drivers
Increasing Prevalence of Chronic Diseases
-
Chronic diseases such as cancer, diabetes, and cardiovascular diseases are increasing worldwide, which is probably the most crucial factor boosting the demand for protein therapeutics. These complex conditions require innovative types of protein-based medicines like biologics and monoclonal antibodies for therapy, permitting targeted therapies and reducing the side effects.
Advancements in Biotechnology and Drug Development
-
The global protein therapeutics market growth is driven by continuous improvements in biotechnology and drug development. Augmenting treatment options and improving therapeutic efficacy designed to create increasingly specialized therapies for complicated conditions include innovative gene therapies, enzyme replacement therapies, and personalized medicine.
Protein Therapeutics Market Restraints
Limited Patient Access and Reimbursement Issues
-
Protein therapeutics are efficacious, but they are largely unattainable for several patients due to the exorbitant costs and lack of insurance coverage. The level of reimbursement varies by region, making these therapies unaffordable for many patients, especially in emerging markets; thus, inhibiting the growth of this market.
Immunogenicity and Side Effects
-
Immunogenicity is one of the major drawbacks associated with protein therapeutics. This refers to the adverse reaction when the immune system reacts to proteins introduced externally as foreign entities. This will restrict their application in long-term treatment and consider safety before their widespread adoption and development.
Request Free Customization of this report to help us to meet your business objectives.
Protein Therapeutics Market Competitive Landscape
The global protein therapeutics market is highly competitive, with several prominent players driving innovation and market growth. Companies in this space include many other marquee names like Amgen, Roche, Novartis, Johnson & Johnson, and AbbVie, all involved in cutting-edge development of biologics, monoclonal antibodies, and enzyme therapy products. These companies spend enormous amounts of money on research and development to enhance their portfolios to meet the future demand for increased therapeutic targeting in oncology, autoimmune or metabolic disorders applications.
Top Player’s Company Profiles
- Amgen Inc. (US)
- AbbVie Inc. (US)
- Roche Diagnostics (Switzerland)
- Eli Lilly and Company (US)
- Johnson & Johnson (US)
- Pfizer Inc. (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novo Nordisk A/S (Denmark)
- Merck & Co., Inc. (US)
- Celgene Corporation (US)
- GlaxoSmithKline PLC (UK)
- Gilead Sciences, Inc. (US)
- Biogen Inc. (US)
- AstraZeneca PLC (UK)
- Takeda Pharmaceutical Company Limited (Japan)
- Abbott Laboratories (US)
- Bayer AG (Germany)
- Alexion Pharmaceuticals Inc. (US)
- Novartis AG (Switzerland)
- Sanofi (France)
Recent Developments
- In October 2023, Lumakras is the latest protein-based drug approved by the U.S. FDA for treating non-small cell lung cancer. The path-breaking monoclonal antibody is therefore well positioned in terms of targeted therapy for cancer. Thus, this demonstrates Amgen's commitment to continuing to expand its oncology pipeline.
- In July 2023, Roche launched this novel protein therapy with Hemlibra, specifically for hemophilia A patients. The therapy acts as a substitute for the deficient clotting factor and will yield better results as compared to the older treatment options available. This approval reaffirms Roche's leadership in the field of innovating hematology.
- In June 2023, A new invention from Johnson & Johnson is a protein-based vaccine for the Respiratory Syncytial Virus (RSV). This protein therapeutics approach is geared to help with fewer hospitalizations and severe symptoms among the most vulnerable populations. The vaccine is just the latest example of the continued effort expected from Johnson & Johnson in innovating targeted biologics for emerging infectious diseases.
Protein Therapeutics Key Market Trends
- Rising Demand for Personalized Medicine: The growing shift toward personalized medicine is driving the global protein therapeutics market trends, with therapies tailored to individual genetic profiles. This trend-potentiating treatment efficacy with least effects has increased demand and needs of advanced drugs, particularly for cancers and other autoimmune diseases, to push the application of targeted biologics and protein therapies further.
- Advancements in Biotechnology and Gene Therapies: Continuous advancements in biotechnology, such as CRISPR and gene editing technologies, are propelling the protein therapeutics market. The efficacy of treatments can improve in precision with the coming of new treatments, particularly those that target rare genetic disorders, metabolic conditions, and cancers, all changing the scope of protein-based therapies and revolutionizing treatments worldwide.
Protein Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, global protein therapeutics industry is thriving as an increase in prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders. In addition to these advances in biotechnology, monoclonal antibodies, insulin therapies, and advances in protein engineering drive market growth.
Targeted therapies may provide treatment changes for cancer and rare diseases, despite high costs and immunogenicity concerns. North America continues to dominate the market, while Asia-Pacific is predicted to be the fastest-growing region. The demand for protein therapeutics will always continue to rise and thus shift away from the global healthcare future.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 6.57 billion |
| Market size value in 2031 | USD 11.10 billion |
| Growth Rate | 6% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Protein Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Protein Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Protein Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Protein Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Protein Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Protein Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
